Skip to content

Mattia Giovenzana

3 papers in the library · 5 citations · publishing 2025-2026

Papers

Sort Most recent Most cited

444. In depth behavioral phenotyping of sex-dependent consequences of maternal separation in mice and effects of psilocybin

The International Journal of Neuropsychopharmacology September 1, 2026 J Mingardi, S Spinosa, N Nicosia et al.

Abstract Background Stress is a recognized risk factor for developmental and adult psychiatric disorders. Indeed, stressful events, particularly during the first phases of life, such as trauma, neglect or abuse, have been associated with increased psychiatric risk over the course of a lifetime, although with some sex-differences. Indeed, the biological sex shapes the stress response impacting...

Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges

Pharmacological Research August 26, 2026 Mattia Giovenzana, Noemi Nicosia, Stefano Spinosa et al.

Neurodevelopmental disorders (NDDs) comprise a heterogeneous group of conditions arising from altered brain development and leading to impairments in social, cognitive, emotional, and motor domains. Clinical manifestations are highly variable in severity and symptom profile, reflecting the complex and multifactorial etiology of NDDs. Available treatments are limited to early behavioral...

Enduring modulation of dorsal raphe nuclei regulates (R,S)-ketamine-mediated resilient stress-coping behavior.

Molecular Psychiatry June 1, 2025 Anderson Camargo, Anna Nilsson, Reza Shariatgorji et al. 5 citations

Ketamine may be a novel pharmacologic approach to enhance resilience and protect against stress-related disorders, but the molecular targets underlying this response remain to be fully characterized. The multifunctional protein p11 is crucial in the pathophysiology of depression and antidepressant responses. However, it is still unclear whether p11 plays a role in the pro-resilience effects...